RankingsPricing
  1. JP-listed companies
  2. KISSEI PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Income before tax

KISSEI PHARMACEUTICAL CO.,LTD.【JP:4547】

Market cap
¥229B
P/E ratio
15.6x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndIncome before tax (Million JPY)YoY (%)
Mar 31, 20256,974+13.55%
Mar 31, 20246,142+927.09%
Mar 31, 2023598+6.41%
Mar 31, 2022562-83.83%
Mar 31, 20213,476+43.10%
Mar 31, 20202,429-66.12%
Mar 31, 20197,169-37.19%
Mar 31, 201811,414+18.43%
Mar 31, 20179,638-15.11%
Mar 31, 201611,353+7.27%
Mar 31, 201510,584-21.84%
Mar 31, 201413,541+53.02%
Mar 31, 20138,849+6.28%
Mar 31, 20128,326

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)